佐藤康史特任教授、友成 哲助教の論文が掲載されました。
1）Sato Y, Okamoto K, Kawaguchi T, Nakamura F, Miyamoto H, Takayama T.
Treatment Response Predictors of Neoadjuvant Therapy for Locally Advanced Gastric Cancer: Current Status and Future Perspectives.
Biomedicines. 2022 Jul 6;10(7):1614.
2）Tomonari T, Tani J, Sato Y, Tanaka H, Tanaka T, Taniguchi T, Morishita A, Okamoto K, Sogabe M, Miyamoto H, Muguruma N, Masaki T, Takayama T.
Initial therapeutic results of atezolizumab plus bevacizumab for unresectable advanced hepatocellular carcinoma and the importance of hepatic functional reserve.
Cancer Med. 2022 Aug 14. doi: 10.1002/cam4.5145. Online ahead of print.
Initial therapeutic results of atezolizumab plus bevacizumab for unresectable advanced hepatocellular carcinoma and the importance of hepatic functional reserve.
Cancer Med. 2022 Aug 14. doi: 10.1002/cam4.5145. Online ahead of print.
